← FDA Drug Approvals (Drugs@FDA)
MEMANTINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: VITRUVIAS · Approved 2022-10-11
Drug application
- FDA Application #
ANDA213985- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MEMANTINE HYDROCHLORIDE
- Generic name
- MEMANTINE HYDROCHLORIDE
- Active ingredients
- MEMANTINE HYDROCHLORIDE
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- VITRUVIAS
- Manufacturer
- Vitruvias Therapeutics, Inc.
- First approval
- 2022-10-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown